- "It takes about 2 x as long for someone with MS to absorb and process information as someone who does not have MS: Back to School With MS? Here's How"
- Multiple Sclerosis Treatment Options: Breakdown of Associated Risks
- Study: Tysabri (Natalizumab) to fingolimod washout in patients at risk of PMLFingolimod, Tysabri
- Neil Cavuto on Feeling Moved to Tell His Viewers: ‘It’s Not Me, It’s The Multiple Sclerosis’
- Merck KGaA shores up Rebif defenses to fend off new MS rivalsRebif
- Play the MS Matching Game: brain games can help exercise your mind
- Survey showed strong uptake of the new 40-milligram, thrice-weekly version of Teva's Copaxone, estimating that about 40% of MSers will have switched to it after two yearsCopaxone
- New warning suggested for Ambien...the same sleeping pill that landed a Kennedy before a jury: says patients shouldn't drive for 8 hours after they take meds like Ambien
- $15 Million awarded to former Newark teacher with MS who says district retaliated against her
- A Glittering Rock Reunion of 14,300 Fans Becomes the Best of Get-Well Gifts for Guitarist Ronnie Lane
- Study: 2014 Multiple Sclerosis Therapeutic Update, UCSF MS Department of Neurology, San Francisco, CA
- Study: High prevalence and no latitude gradient of multiple sclerosis in Norway
- Study: Supervised exercise training has substantial benefits for MSers, yet 80% of those with MS do not meet recommended levels of moderate-to-vigorous physical activity (MVPA)
- "British Health Minister Edwin Poots witnessed first-hand how oxygen therapy can help MSers enjoy a better quality of life"
- Illinois lottery game fund multiple sclerosis research
- BREAKING NEWS! WARNING: Pfizer Issues Nationwide Recall of Antidepressant Effexor
- For Runner With M.S., No Pain While Racing, No Feeling at the Finish (New York Times)
- A MSer's story of how she & her Neuro both had problems with Anthem BlueCross getting her MS treatment refilled:10 BEST
- Doctors’ #1 Source for Healthcare Information: Wikipedia
- Merck KGaA shores up Rebif defenses to fend off new MS rivals
- Novartis, Sanofi, Biogen tout new MS drug researchAubagio, Copaxone, Gilenya, Tysabri
- My recent struggles made me realize, you only live life one time
- "Innate Immunotherapeutics delivered results from animal studies which further support its novel MIS416 therapy as a candidate to treat Secondary Progressive Multiple "Sclerosis (SPMS)
- Oregon Health & Science University today announced the creation of the OHSU Center for Embryonic Cell and Gene Therapy, led by Shoukhrat Mitalipov, Ph.D., a world-renowned leader in embryonic stem cell and gene therapy research
- Study: Neglecting data from individuals with MS who exhibit head movement during functional magnetic resonance imaging (fMRI) scanning may bias sampling away from individuals with lower cognitive ability
- Study: MiR-126: a novel route for Tysabri (natalizumab) action?Tysabri
- "Dr. Monson has developed a validated method for pre-testing people living with MS to determine if they are a carrier of a unique antibody gene that leads to the disease, thus mitigating the long-standing challenge of diagnosis"
- MS trial to explore vitamin D links
- Study: Oxygen Cost of Walking in Persons with Multiple Sclerosis: Disability Matters, but Why?
- A SAD BUT IMPORTANT LESSON FOR ALL MSers: "Inquest hears how MSer dropped match or cigarette onto her bed that engulfed her in flames and burnt down her home
- This MSer believes marijuana helped put his MS in remission: soon however, Davidson will be forced to destroy the medicine he credits with saving his life
- Biogen Idec finished 2013 on a high note, with its highly touted oral multiple sclerosis drug Tecfidera producing nearly $400 million in sales during the fourth
- Study Findings from Biogen Idec, Inc. Provide New Insights into Multiple Sclerosis
- Slightest change makes myelin come unglued: One common characteristic of diseased myelin is swelling due to MS
- OMG of the week: Doctors flee homes after declaring strike
- What Do Healthcare Providers Advise Women with Multiple Sclerosis Regarding Pregnancy?
- How Inactivity Change MSer's Brains
- One-liners may hint at feelings about health care
- RUNNING HELPS ME MANAGE MY MS: Jeanine Parson
- I'm a mother of 3 young children and here's my horror story of my MS & the new health care law
- TAKEDA ADMITS TO IMPROPERLY MARKETING BLOCKBUSTER DRUG a AFTER DOCTOR POINTS OUT DATA IN AD DIDNT MATCH RESULTS OF CLINICAL STUDY
- Study: “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis
- Clues To Causes Of Nerve Cell Degeneration in MS Provided By Spasticity Gene Finding
- Minn. physicians ponder medical pot: Is marijuana an effective treatment for pain, illness and disease?
- Study: MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge
- Variables associated with patient activation in persons with multiple sclerosis
- What Vitamin D Dosage Do I need? How Much Sun Do I Need?
- Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
- Express Scripts stops covering older, commonly used treatments such as Bayer's multiple sclerosis drug Betaseron on clinical, cost-effectiveness grounds
- Study: Antiviral drug Ganciclovir Inhibits Neuroinflammation in Mouse Model of MS
- Myelin basic protein-diverse conformational states of an intrinsically unstructured protein and its roles in myelin assembly and multiple sclerosis
- Study: Constraint-induced movement therapy increased neuroplasticity in MS patients according to MRI findings, whereas massage, yoga, and other "complementary/alternative medicine" treatments did not.
- Arshiya’s special talent: I used to jump all the way down the steps in Hodge Lee in one leap. I felt like Superman, or rather, Superwoman. That was before I got MS
- TEVA'S COPAXONE PATENT IS UP AND ITS DESPERATE TO KEEP PATIENTS & INSURERS
- DOES THIS NEW STUDY MEAN ANYTHING FOR MS PATIENTS?: "Medical Marijuana: Studies Find No Benefit for RA: Rheumatologists should not currently be recommending the use of medical marijuana to their patients for relief of chronic pain, researchers stated
- 4 Things All Doctors Need To Know About Health IT Security
- Video: THE SCANDAL THAT ROCKED THE PATIENT SAFETY MOVEMENT BREAK...
- CAN CAFFEINE HELP AN MSers MEMORY: Caffeine’s little memory jolt garners a lot of excitement
- Air Force Academy's future rests in Lt. Gen. Michelle Johnson steady hands: the institution's first female superintendent, has been tearing down barriers all her life including MS
- Senate Passes Casey MS Resolution Ahead of Multiple Sclerosis Awareness Week
- "MS doesn't define us - it's just there"
- 7 women are suing Doctor & health network for medical negligence, claiming the doctor misdiagnosed them with multiple sclerosis
- "My 1st experience as an immunologist diagnosed with MS" by Griselda Zuccarino-Catina, PH.D.
- DOCTORS BEDSIDE MANNER: written by a doctor
- Immunophenotyping Separates MS Subtypes by Neuroinflammation
- What's new in the fight against MS? USA Today
- Another big beast joins the MS Drug fray: ofatumumab phase 2 trial results
- MSnewsChanel.com.com
- Study may provide future insights into causes and mechanisms of MS
- 30% of the 16,651 people who died of an opioid overdose also had taken a benzodiazepine
- Working as a full time police officer & living with MS
- Here's 5 ways to help ease the pain of winter months
- Obamacare Hikes Cost to Patients of Specialty Drugs for MS
- The battle of a 6th grader recently diagnosed with MS
- Study: Stethoscopes carry more bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA), than a physician’s hand
- Merck's Rebif is a 3rd major MS drug to be discovered in Israel: The Israeli Connection
- Kristen discovers running as way to combat her MS
- Cara Therapeutics has exciting new MS drugs in their pipeline
- Study: See One, Do One: Watching Action Boosts Brain Volume, Ability
- Study: Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection
- We've posted 314 Studies & Stories for you so far this week
- FOR DOCTORS ONLY: 15 Smartphone Apps to Improve Your PracticeDocs Only
- WEEKEND LOL REPORT: Medical School Limiting the Number of Creepy Applicants to Cut Down on Creepy Doctors
- Video: 'Dallas Buyers Club' connects with MSers
- FOR DOCTORS ONLY: Study Companion: Mastering Clinical Concepts in MS Management
Copaxone is owned by Teva....All news received directly from Teva or it's websites is in green